253 related articles for article (PubMed ID: 8606627)
1. The glucagonoma syndrome. Clinical and pathologic features in 21 patients.
Wermers RA; Fatourechi V; Wynne AG; Kvols LK; Lloyd RV
Medicine (Baltimore); 1996 Mar; 75(2):53-63. PubMed ID: 8606627
[TBL] [Abstract][Full Text] [Related]
2. Necrolytic migratory erythema is an important visual cutaneous clue of glucagonoma.
Li W; Yang X; Deng Y; Jiang Y; Xu G; Li E; Wu Y; Ren J; Ma Z; Dong S; Han L; Ma Q; Wu Z; Wang Z
Sci Rep; 2022 May; 12(1):9053. PubMed ID: 35641533
[TBL] [Abstract][Full Text] [Related]
3. A review of cutaneous manifestations within glucagonoma syndrome: necrolytic migratory erythema.
Tolliver S; Graham J; Kaffenberger BH
Int J Dermatol; 2018 Jun; 57(6):642-645. PubMed ID: 29450880
[TBL] [Abstract][Full Text] [Related]
4. Endocrine pancreatic tumors with glucagon hypersecretion: a retrospective study of 23 cases during 20 years.
Kindmark H; Sundin A; Granberg D; Dunder K; Skogseid B; Janson ET; Welin S; Oberg K; Eriksson B
Med Oncol; 2007; 24(3):330-7. PubMed ID: 17873310
[TBL] [Abstract][Full Text] [Related]
5. [The question of surgical therapy for necrolytic migratory erythema, a cutaneous disease].
Siegel R; Linse R; Rau B
Chirurg; 2006 Jun; 77(6):535-8. PubMed ID: 16362349
[TBL] [Abstract][Full Text] [Related]
6. Glucagonoma and the glucagonoma syndrome - cumulative experience with an elusive endocrine tumour.
Eldor R; Glaser B; Fraenkel M; Doviner V; Salmon A; Gross DJ
Clin Endocrinol (Oxf); 2011 May; 74(5):593-8. PubMed ID: 21470282
[TBL] [Abstract][Full Text] [Related]
7. Necrolytic migratory erythema: first symptom of a glucagonoma. A case report.
Du Jardin P; Cools P; Van der Stighelen Y
Acta Chir Belg; 2004 Aug; 104(4):468-70. PubMed ID: 15469167
[TBL] [Abstract][Full Text] [Related]
8. Necrolytic migratory erythema and glucagonoma rising from pancreatic head.
Tseng HC; Liu CT; Ho JC; Lin SH
Pancreatology; 2013; 13(4):455-7. PubMed ID: 23890147
[TBL] [Abstract][Full Text] [Related]
9. Characteristics and treatment options of glucagonomas: a national study from the French Group of Endocrine Tumors and ENDOCAN-RENATEN network.
Perrier M; Brugel M; Gérard L; Goichot B; Lièvre A; Lepage C; Hautefeuille V; Do Cao C; Smith D; Thuillier P; Cros J; Cadiot G; Walter T; de Mestier L
Eur J Endocrinol; 2023 Dec; 189(6):575-583. PubMed ID: 38039101
[TBL] [Abstract][Full Text] [Related]
10. Rare presentation of endocrine pancreatic tumor: a case of diffuse glucagonoma without metastasis and necrolytic migratory erythema.
Chen HW; Chen HW; Su DH; Shun CT; Liu KL
J Formos Med Assoc; 2005 May; 104(5):363-6. PubMed ID: 15959605
[TBL] [Abstract][Full Text] [Related]
11. Putting the pieces together: necrolytic migratory erythema and the glucagonoma syndrome.
Halvorson SA; Gilbert E; Hopkins RS; Liu H; Lopez C; Chu M; Martin M; Sheppard B
J Gen Intern Med; 2013 Nov; 28(11):1525-9. PubMed ID: 23681843
[TBL] [Abstract][Full Text] [Related]
12. Glucagonoma syndrome.
Bloom SR; Polak JM
Am J Med; 1987 May; 82(5B):25-36. PubMed ID: 2884877
[TBL] [Abstract][Full Text] [Related]
13. Rare presentation of endocrine pancreatic tumour: a case of glucagonoma without necrolytic migratory erythema?
Manes G; Pellegrini A; Riccardi F; Uomo G
Ital J Gastroenterol; 1995 Jun; 27(5):248-9. PubMed ID: 8541575
[TBL] [Abstract][Full Text] [Related]
14. Necrolytic Migratory Erythema: A Forgotten Paraneoplastic Condition.
Tremblay C; Marcil I
J Cutan Med Surg; 2017; 21(6):559-561. PubMed ID: 28662584
[TBL] [Abstract][Full Text] [Related]
15. Clinical spectrum of hyperglucagonemia associated with malignant neuroendocrine tumors.
Wermers RA; Fatourechi V; Kvols LK
Mayo Clin Proc; 1996 Nov; 71(11):1030-8. PubMed ID: 8917287
[TBL] [Abstract][Full Text] [Related]
16. Glucagonoma syndrome: a case report.
Shyr YM; Su CH; Lee CH; Wu CW; Lui WY
Zhonghua Yi Xue Za Zhi (Taipei); 1999 Sep; 62(9):639-43. PubMed ID: 10502856
[TBL] [Abstract][Full Text] [Related]
17. Dermatitis, glossitis, stomatitis, cheilitis, anemia and weight loss: a classic presentation of pancreatic glucagonoma.
Povoski SP; Zaman SA; Ducatman BS; McFadden DW
W V Med J; 2002; 98(1):12-4. PubMed ID: 11941895
[TBL] [Abstract][Full Text] [Related]
18. Necrolytic migratory erythema, first symptom of a malignant glucagonoma: treatment by long-acting somatostatin and surgical resection. Report of three cases.
El Rassi Z; Partensky C; Valette PJ; Berger F; Chayvialle JA
Eur J Surg Oncol; 1998 Dec; 24(6):562-7. PubMed ID: 9870735
[TBL] [Abstract][Full Text] [Related]
19. The glucagonoma syndrome and necrolytic migratory erythema: a clinical review.
van Beek AP; de Haas ER; van Vloten WA; Lips CJ; Roijers JF; Canninga-van Dijk MR
Eur J Endocrinol; 2004 Nov; 151(5):531-7. PubMed ID: 15538929
[TBL] [Abstract][Full Text] [Related]
20. Glucagonoma With Necrolytic Migratory Erythema: Metabolic Profile and Detection of Biallelic Inactivation of DAXX Gene.
Tamura A; Ogasawara T; Fujii Y; Kaneko H; Nakayama A; Higuchi S; Hashimoto N; Miyabayashi Y; Fujimoto M; Komai E; Kono T; Sakuma I; Nagano H; Suzuki S; Koide H; Yokote K; Iseki K; Oguma R; Matsue H; Nojima H; Sugiura K; Yoshitomi H; Ohtsuka M; Rahmutulla B; Kaneda A; Inoshita N; Ogawa S; Tanaka T
J Clin Endocrinol Metab; 2018 Jul; 103(7):2417-2423. PubMed ID: 29688432
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
